12:00 AM
 | 
Sep 15, 2014
 |  BC Week In Review  |  Company News  |  Deals

Alpine Biosciences, Oncothyreon deal

Oncothyreon acquired drug delivery company Alpine for 9.2 million Oncothyreon shares, or about $27.1 million based on Oncothyreon's close of $2.93 on Aug. 8, before...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >